Neuropathix, Inc. Announces Publication of Validated Preclinical Studies on KLS-13019 in the British Journal of Pharmacology
May 06, 2021 09:00 ET
|
Neuropathix, Inc.
DOYLESTOWN, Pa., May 06, 2021 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (“Neuropathix” or the “Company”) (OTCQB: NPTX), a socially responsible pain management life sciences company, announced today the...
Neuropathix, Inc. CEO Recaps 2020 Advances and Potential Ahead
January 25, 2021 09:00 ET
|
Neuropathix, Inc.
DOYLESTOWN, Pa., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (“Neuropathix” or the “Company”) (OTCQB: NPTX), a socially responsible pain management life sciences company, announced today...
Neuropathix, Inc. Announces Publication of Its Global PCT Patent for NPTX-204, a Novel Hops-Inspired Neuroprotectant
January 19, 2021 09:00 ET
|
Neuropathix, Inc.
DOYLESTOWN, Pa., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (“Neuropathix” or the “Company”) (OTCQB: NPTX), a socially responsible pain management life sciences company, announced the...
Neuropathix, Inc. Appoints World-Renowned Pain Management Clinician Dr. Daniel Richman to the Company’s Scientific Advisory Board
January 12, 2021 09:00 ET
|
Neuropathix, Inc.
DOYLESTOWN, Pa., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Neuropathix, Inc. ("Neuropathix" or the “Company”) (OTCQB: NPTX), a socially responsible pain management life sciences company, announced today...
Neuropathix, Inc. Acquires Neuroprotective and Anticonvulsant Intellectual Property Estate
December 21, 2020 09:00 ET
|
Neuropathix, Inc.
DOYLESTOWN, Pa., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (OTCQB: NPTX), (the “Company” or "Neuropathix"), a socially responsible pain management life sciences company, announced today...
Neuropathix, Inc. Signs Binding Letter of Intent to Acquire Anticonvulsant – Neuroprotective Intellectual Property
November 19, 2020 09:00 ET
|
Neuropathix, Inc.
DOYLESTOWN, Pa., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (OTCQB: NPTX), formerly Kannalife, Inc. (the “Company” or "Neuropathix"), a socially responsible pain management life sciences...
Neuropathix, Inc. Reveals Visual Identity to Coincide With Its Mission for Socially Responsible Pain Management
November 12, 2020 09:00 ET
|
Neuropathix, Inc.
DOYLESTOWN, Pa., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Neuropathix, Inc. ("Neuropathix" or the “Company”) (OTCQB: NPTX), formerly Kannalife, Inc., is a socially responsible pain management life sciences...
Kannalife, Inc. Rebrands as Neuropathix, Inc. and Unveils New Ticker Symbol
November 06, 2020 09:00 ET
|
Neuropathix, Inc.
DOYLESTOWN, Pa., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical and medchem company specializing in the research and development...
Kannalife, Inc. Adds to Its Global IP Estate Receiving Patent Grant from Canada for Its Novel Anti-Inflammatory Compounds
October 06, 2020 09:00 ET
|
Kannalife, Inc.
DOYLESTOWN, Pa., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical and medchem company specializing in the research and development...
Kannalife, Inc. Appoints Dr. Tage Honoré as Chairman of the Company’s Board of Advisors
September 17, 2020 09:00 ET
|
Kannalife, Inc.
DOYLESTOWN, Pa., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical medicinal chemistry company specializing in the research and...